These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 24832197)

  • 1. Evaluating the role of inflammation in chronic airways disease: the ERICA study.
    Mohan D; Gale NS; McEniery CM; Bolton CE; Cockcroft JR; MacNee W; Fuld J; Lomas DA; Calverley PM; Shale DJ; Miller BE; Wilkinson IB; Tal-Singer R; Polkey MI;
    COPD; 2014 Sep; 11(5):552-9. PubMed ID: 24832197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinogen does not relate to cardiovascular or muscle manifestations in COPD: cross-sectional data from the ERICA study.
    Mohan D; Forman JR; Allinder M; McEniery CM; Bolton CE; Cockcroft JR; MacNee W; Fuld J; Marchong M; Gale NS; Fisk M; Nagarajan S; Cheriyan J; Lomas DA; Calverley PMA; Miller BE; Tal-Singer R; Wilkinson IB; Polkey MI;
    Thorax; 2018 Dec; 73(12):1182-1185. PubMed ID: 29618495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular risk prediction using physical performance measures in COPD: results from a multicentre observational study.
    Fermont JM; Fisk M; Bolton CE; MacNee W; Cockcroft JR; Fuld J; Cheriyan J; Mohan D; Mäki-Petäjä KM; Al-Hadithi AB; Tal-Singer R; Müllerova H; Polkey MI; Wood AM; McEniery CM; Wilkinson IB;
    BMJ Open; 2020 Dec; 10(12):e038360. PubMed ID: 33372069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Reproducibility of strength and endurance measurements of the quadriceps in patients with COPD].
    Beaumont M; Kerautret G; Peran L; Pichon R; Le Ber C; Cabillic M
    Rev Mal Respir; 2017 Nov; 34(9):1000-1006. PubMed ID: 29033203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surrogate Markers of Cardiovascular Risk and Chronic Obstructive Pulmonary Disease: A Large Case-Controlled Study.
    Fisk M; McEniery CM; Gale N; Mäki-Petäjä K; Forman JR; Munnery M; Woodcock-Smith J; Cheriyan J; Mohan D; Fuld J; Tal-Singer R; Polkey MI; Cockcroft JR; Wilkinson IB;
    Hypertension; 2018 Mar; 71(3):499-506. PubMed ID: 29358458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex differences in COPD-related quadriceps muscle dysfunction and fibre abnormalities.
    Sharanya A; Ciano M; Withana S; Kemp PR; Polkey MI; Sathyapala SA
    Chron Respir Dis; 2019; 16():1479973119843650. PubMed ID: 31131626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating testosterone levels and health outcomes in chronic obstructive pulmonary disease: results from ECLIPSE and ERICA.
    Pavey H; Polkey MI; Bolton CE; Cheriyan J; McEniery CM; Wilkinson I; Mohan D; Casaburi R; Miller BE; Tal-Singer R; Fisk M
    BMJ Open Respir Res; 2023 Jun; 10(1):. PubMed ID: 37316306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fixed Handheld Dynamometry Provides Reliable and Valid Values for Quadriceps Isometric Strength in People With Chronic Obstructive Pulmonary Disease: A Multicenter Study.
    Bui KL; Mathur S; Dechman G; Maltais F; Camp P; Saey D
    Phys Ther; 2019 Sep; 99(9):1255-1267. PubMed ID: 30939198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arterial stiffness measured via carotid femoral pulse wave velocity is associated with disease severity in COPD.
    Cinarka H; Kayhan S; Gumus A; Durakoglugil ME; Erdogan T; Ezberci I; Yavuz A; Ozkaya S; Sahin U
    Respir Care; 2014 Feb; 59(2):274-80. PubMed ID: 23821765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Peripheral muscle dysfunction in chronic obstructive pulmonary disease].
    Roca M; Mihăescu T
    Pneumologia; 2012; 61(3):178-82. PubMed ID: 23173381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gait characteristics and their associations with clinical outcomes in patients with chronic obstructive pulmonary disease.
    Iwakura M; Okura K; Shibata K; Kawagoshi A; Sugawara K; Takahashi H; Shioya T; Wakasa M
    Gait Posture; 2019 Oct; 74():60-65. PubMed ID: 31470225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aerobic exercise training does not alter vascular structure and function in chronic obstructive pulmonary disease.
    Gelinas JC; Lewis NC; Harper MI; Melzer B; Agar G; Rolf JD; Eves ND
    Exp Physiol; 2017 Nov; 102(11):1548-1560. PubMed ID: 28857336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aortic Pulse Wave Velocity as a Measure of Cardiovascular Risk in Chronic Obstructive Pulmonary Disease: Two-Year Follow-Up Data from the ARCADE Study.
    Gale NS; Albarrati AM; Munnery MM; Mcdonnell BJ; Benson VS; Singer RMT; Cockcroft JR; Shale DJ
    Medicina (Kaunas); 2019 Apr; 55(4):. PubMed ID: 30987061
    [No Abstract]   [Full Text] [Related]  

  • 14. Subclinical cardiovascular disease in patients with chronic obstructive pulmonary disease: a systematic review.
    Ye C; Younus A; Malik R; Roberson L; Shaharyar S; Veledar E; Ahmad R; Ali SS; Latif MA; Maziak W; Feiz H; Aneni E; Nasir K
    QJM; 2017 Jun; 110(6):341-349. PubMed ID: 27539486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of Risk in Chronic Airways Disease Evaluation (ARCADE): Protocol and preliminary data.
    Gale NS; Albarrati AM; Munnery MM; Munnery IC; Irfan M; Bolton CE; Rambaran CN; Singer RM; Cockcroft JR; Shale DJ
    Chron Respir Dis; 2014 Nov; 11(4):199-207. PubMed ID: 25159833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carotid stiffness and atherosclerotic risk: non-invasive quantification with ultrafast ultrasound pulse wave velocity.
    Zhu ZQ; Chen LS; Wang H; Liu FM; Luan Y; Wu LL; Liu N; Wang P; Huang H
    Eur Radiol; 2019 Mar; 29(3):1507-1517. PubMed ID: 30187117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the 1-minute sit-to-stand test a good tool for the evaluation of the impact of pulmonary rehabilitation? Determination of the minimal important difference in COPD.
    Vaidya T; de Bisschop C; Beaumont M; Ouksel H; Jean V; Dessables F; Chambellan A
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2609-2616. PubMed ID: 27799759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Inspiratory Muscle Training and Calisthenics-and-Breathing Exercises in COPD With and Without Respiratory Muscle Weakness.
    Basso-Vanelli RP; Di Lorenzo VA; Labadessa IG; Regueiro EM; Jamami M; Gomes EL; Costa D
    Respir Care; 2016 Jan; 61(1):50-60. PubMed ID: 26556894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiplatelet therapy in the primary prevention of cardiovascular disease in patients with chronic obstructive pulmonary disease: protocol of a randomised controlled proof-of-concept trial (APPLE COPD-ICON 2).
    Kunadian V; Chan D; Ali H; Wilkinson N; Howe N; McColl E; Thornton J; von Wilamowitz-Moellendorff A; Holstein EM; Burns G; Fisher A; Stocken D; De Soyza A;
    BMJ Open; 2018 May; 8(5):e020713. PubMed ID: 29804061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of quadriceps muscle weakness in patients with COPD and its association with disease severity.
    Kharbanda S; Ramakrishna A; Krishnan S
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1727-35. PubMed ID: 26366065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.